Endostart, a medical device company specialising in gastrointestinal endoscopy solutions, has announced a ‘major breakthrough’ with the FDA 510(k) clearance of its flagship product, Endorail. Endorail is a magnetic balloon solution that optimises colonoscopy procedural outcomes.

The company says this achievement represents a significant step forward in advancing the field of gastrointestinal endoscopy and improving patient care worldwide.

Now available commercially in the US, Endorail is said to enhance the efficiency and safety of endoscopic procedures, offering a solution to solve looping and facilitate the competition of prolonged colonoscopies. Designed to streamline the colonoscopy process, Endorail combines its magnetic balloon solution with user-friendly features, which the company says empowers physicians to overcome procedural challenges with ‘confidence and precision’.

With Endorail, physicians gain access to an on-demand tool that optimises procedural outcomes as well as reducing the healthcare costs associated with prolonged or incomplete procedures.

Colonoscopy remains a cornerstone procedure for the diagnosis, surveillance, prevention and treatment of various colon diseases, including colorectal cancer and chronic inflammatory bowel diseases.